Biologic Videos

  1. Drug Discovery Beyond Rule Of Five: ECCS Class 3 And 4 Strategies 2/3/2026

    Gain practical guidance for advancing bRo5 candidates through improved permeability and metabolic stability with insights on ECCS classes 3 and 4, optimized in vitro tools, and design principles.

  2. How Can We Make Drug Discovery Faster And Smarter? 2/3/2026

    DEL technology is evolving from a screening tool into a rich data engine for AI. Learn how expanding datasets and computational methods are reshaping what researchers can uncover.

  3. Viral Clearance Strategies For Monoclonal Antibodies And Proteins 1/30/2026

    Guidance on designing viral clearance studies using regulatory-aligned, risk‑based strategies, optimized assays, and real case examples for safe, efficient biologics development.

  4. A Trusted New Partnership 1/28/2026

    Optima delivers high‑quality, flexible syringe and vial filling solutions with fast qualification, U.S.‑based support, and long‑term partnership reliability, helping CDMOs scale efficiently and confidently.

  5. Commercially Proven Sterile Fill/Finish With Capacity And Global Backing 1/27/2026

    Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

  6. PCI Pharma Services Capabilities Update January 2026: Fill/Finish 1/27/2026

    Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.

  7. Afton Scientific Capabilities Update January 2026: Fill/Finish 1/27/2026

    Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.

  8. Drug Product Development: Preclinical To Commercial 1/26/2026

    Watch a unified roadmap for drug product development, outlining phase‑appropriate studies, QTTP importance, and key requirements from preclinical stages through commercialization.

  9. Understanding Surfactant Excipients In Biologic Formulations 1/26/2026

    Uncover surfactant characterization, polysorbate degradation, and advanced analytics, such as multidimensional LC, to strengthen stability assessment and formulation for biologics and advanced therapies.

  10. Detecting Particles In Biologic And CGT Drug Products 1/26/2026

    Identify and characterize visible and subvisible particles that can form during biologic and cell or gene therapy development.